When even Jon Stewart says President Trump “did a solid,” Washington’s usual partisan script breaks—because the policy targets a decades-long bureaucracy that has kept promising PTSD treatments from many veterans.
Story Snapshot
- President Trump signed an executive order on April 18, 2026 aimed at accelerating medical treatments for serious mental illness, with a focus on veterans.
- Jon Stewart aired a segment on April 21 praising the move—an unusual moment of cross-partisan credit from a longtime Trump critic.
- The order is framed as a push to speed FDA pathways and expand access to psychedelic-assisted therapies for conditions like PTSD, TBI, depression, and addiction.
- The initiative highlights a broader, bipartisan frustration: federal red tape can outlast administrations and block urgent solutions.
A rare moment of agreement—and why it matters
President Trump’s April 18 executive order, titled “Accelerating Medical Treatments for Serious Mental Illness,” drew unusual praise from comedian and commentator Jon Stewart after his April 21 segment highlighting the policy. Stewart, known for sharp criticism of Trump, said he wanted to “give credit where credit is due,” emphasizing that the order could help veterans access treatments faster. In today’s hyper-polarized media, that kind of acknowledgment is rare—and that rarity is part of the story.
President Trump signed the order in the Oval Office with a high-profile group present, including Joe Rogan, Robert F. Kennedy Jr., Dr. Mehmet Oz, and Navy SEAL Marcus Luttrell. The public optics were clear: the White House wanted a coalition that looks part medical, part cultural, and part veteran-focused. That staging may be politically savvy, but the more important question is operational—whether federal agencies can move quickly without creating new layers of process.
What the executive order targets inside the federal system
The order’s core promise is speed: it directs the government to accelerate pathways for treatments addressing serious mental illness, with specific attention to veterans suffering from PTSD and related conditions. The research summary describes expedited FDA review, safe-use protocols, Right to Try pathways, expanded Veterans Affairs data sharing, and support for expanded studies. Those pieces matter because they touch the choke points where promising therapies often stall—regulatory timelines, controlled-substance rules, and fragmented health data.
Much of the friction traces back to the 1970 Controlled Substances Act, which placed many psychedelics into Schedule I status and made research and medical development difficult. Supporters argue that decades of restrictions created bureaucratic barriers that did not keep pace with emerging evidence or with veterans’ urgent needs. Critics often worry about safety, abuse, and overpromising. The challenge for the administration will be balancing faster access with credible guardrails that protect patients and maintain public trust.
Why veterans’ PTSD care is a political flashpoint in 2026
Veterans’ mental health sits at the intersection of culture and governance: many Americans want the government to keep its promises to those who served, but they also distrust sprawling bureaucracies that move slowly and spend heavily. The executive order aims at a concrete pain point—treatment-resistant PTSD, traumatic brain injury, depression, and addiction—where conventional approaches have not worked for everyone. If the order reduces delay, it would reinforce a core conservative argument: government should deliver results, not paperwork.
The “deep state” question: implementation versus announcements
Stewart’s segment also underscored a shared frustration across the right and left: entrenched systems can block change regardless of who wins elections. The research notes limited public detail on specific mechanisms, funding amounts, or implementation timelines beyond the signing and general components. That missing detail matters because executive orders can be strong signals but uneven tools, especially when agencies must write guidance, coordinate with the VA, and navigate federal drug rules. Americans have learned to ask what changes on the ground.
Watch: Jon Stewart Gives Trump Rare Credit https://t.co/OY8ZhmNxnB
— zerohedge (@zerohedge) April 22, 2026
The political takeaway is not that a comedian’s praise legitimizes a policy, but that cross-aisle agreement can spotlight issues where government inertia has been the real opponent. If the expedited pathways lead to safe, evidence-based options for veterans, the order could become a template for how Washington tackles urgent health problems without waiting years for consensus. If it bogs down, it will reinforce the public’s belief that institutions protect themselves first—no matter who holds power.
Sources:
Watch: Jon Stewart Gives Trump Rare Credit
